Company Announcements

Share Repurchase Programme

Source: RNS
RNS Number : 5397F
Serco Group PLC
05 March 2024
 

5 March 2024

LEI: 549300PT2CIHYN5GWJ21

Serco Group plc

(Serco or the Company)

Share Repurchase Programme

Serco today announces that, as outlined in the announcement of its 2023 Full Year Results on 29 February 2024, it intends to repurchase shares with a value of up to £140 million (the Programme).

Serco has instructed Barclays Capital Securities Limited (Barclays) and J.P. Morgan Securities plc (JPMS), together the Brokers, to execute the Programme.

Serco has entered into a non-discretionary and irrevocable instruction with Barclays in relation to the purchase by Barclays, acting as riskless principal during the period commencing today and ending no later than 5 August 2024, of the Company's Ordinary Shares of 2 pence each (Ordinary Shares) for an aggregate purchase price of up to £70 million.  Following completion, or any termination of such instruction, the Programme will continue under a second non-discretionary and irrevocable instruction with JPMS in relation to the purchase by JPMS, acting as riskless principal during the period commencing following the end of the Barclays instruction and ending no later than 31 December 2024, subject to suspension for certain exceptional and/or unforeseen circumstances, of further Ordinary Shares for an aggregate purchase price of up to £70 million.     

The aggregate number of shares acquired by the Company shall not exceed 115,617,039 Ordinary Shares as authorised by shareholders at the 2023 Annual General Meeting. It is intended that any Ordinary Shares purchased under the Programme will be transferred into treasury and subsequently cancelled. This arrangement is in accordance with Chapter 12 of the Financial Conduct Authority's Listing Rules and the Company's general authority to repurchase shares.

The aggregate purchase price of the Ordinary Shares bought by the Brokers under the two instructions shall be no greater than £140 million. Each of the Brokers shall make a simultaneous on-sale of Ordinary Shares purchased under the instructions to Serco. The Brokers will make their trading decisions in relation to the Programme independently of, and uninfluenced by, Serco.

The Brokers may undertake transactions in Ordinary Shares (which may include sales and hedging activities, in addition to purchases which may take place on any available trading venue or on an over the counter basis) during the period of the Programme in order to manage their market exposure under the Programme. Disclosure of such transactions will not be made by the relevant Broker as a result of or as part of the Programme, but the Brokers will continue to make any disclosures they are otherwise legally required to make.

Ends

 

For further information please contact:

Paul   Checketts, Head  of   Investor  Relations, tel:   +44   (0)   7718  195   074   or email: paul.checketts@serco.com

Marcus De  Ville,  Head of   Media  Relations, tel: +44 (0)   7738  898   550 or email: marcus.deville@serco.com

 

About Serco

Serco brings together the right people, the right technology and the right partners to create innovative solutions that make positive impact and address some of the most urgent and complex challenges facing the modern world.  With a primary focus on serving governments globally, Serco's services are powered by more than 50,000 people working across defence, space, migration, justice, healthcare, mobility and customer services. Serco's core capabilities include service design and advisory, resourcing, complex programme management, systems integration, case management, engineering, and asset & facilities management. Underpinned by Serco's unique operating model, Serco drives innovation and supports customers from service discovery through to delivery. More information can be found at www.serco.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUSAWRSKUORAR